Theracle
PrivateLast Round
VC Round
Oct 6, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Theracle is a medical technology company developing an implantable drug-delivery platform designed to bypass the blood-brain barrier for the treatment of neurological conditions and brain cancers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theracle Comparables
Compare Theracle with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cognos Therapeutics Inc | 86% | |
| CraniUS Therapeutics | 85% | |
| Carthera | 78% |
Theracle Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 6, 2025 | ||||
| Accelerator | May 2, 2013 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 6, 2025
Raised a VC Round with participation from Neuroceuticals Inc.
- May 2, 2013
Accelerator round led by InCube Labs
Theracle Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Theracle's valuation, stock price, and market status.
Is Theracle a public or private company?
Theracle is a private company.
What is the current stock price of Theracle?
Theracle is a private company with no public stock price. No recent secondary market data is available.
How much is Theracle worth (valuation)?
Valuation information for Theracle is not publicly available.
Can I buy Theracle stock?
Theracle shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Theracle's last funding round?
Theracle's most recent funding round was VC Round on October 6, 2025.
Who are the main investors in Theracle?
Investor information for Theracle is not publicly disclosed.
Will Theracle IPO soon?
No public IPO plans have been announced for Theracle.
How can I track Theracle secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Theracle's secondary market activity and sign up for updates.